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The myeloperoxidase (MPO)-derived oxidant
hypochlorous acid (HOCl/OCl) is implicated
in the pathogenesis of atherosclerosis and
other inflammatory states. We have synthe-
sized an imaging probe, sulfonaphthoamino-
phenyl fluorescein (SNAPF), that selectively
reacts with HOCl. SNAPF detects HOCl pro-
duced by stimulated MPO-expressing cells cul-
tured from human whole blood, as well as HOCl
from bone marrow (BM)-derived macrophages
isolated from transgenic mice that express
human MPO. Two lines of evidence indicate
that SNAPF permits the in vivo imaging of
HOCl production. First, we used this approach
to demonstrate HOCl production by neutrophils
in experimental murine peritonitis. Second, we
detected HOCl production by MPO expressing
cells in human atherosclerotic arteries. Thus,
fluorescence reflectance imaging by SNAPF
may provide a valuable noninvasive molecular
imaging tool for implicating HOCl and MPO in
the damage of inflamed tissues.
INTRODUCTION
Oxidative stress likely participates in the pathogenesis of
diseases as diverse as cancer [1], those that affect the
lungs [2], and skin disease [3]. Oxidative processes in
tissues can involve Fenton reactions, in which free metal
ions (most commonly, Fe2+) interact with peroxide to yield
oxidizing products such as the hydroxyl radical and su-
peroxide [4–6]. An alternative pathway for the production
of oxidizing agents, independent of Fenton chemistry,
involves the action of myeloperoxidase (MPO). MPO is
a heme enzyme secreted in large amounts by activated
neutrophils along with superoxide. Superoxide dismutates
spontaneously or enzymatically to hydrogen peroxide,Chemistry & Biology 14, 1221–1231a relatively unreactive oxidant, which is then used as
a substrate by MPO to produce hypochlorous acid
(HOCl) [7]. With a pKa of 7.463 at 35
 [8], under physiolog-
ical conditions, approximately half of the HOCl dissociates
to the hypochlorite anion (OCl), one of the most powerful
natural oxidants. Hypochlorite likely functions to injure
microorganisms oxidatively; however, it can also have
detrimental effects on host tissue. Neutrophil derived
HOCl has been implicated in lung injury [9–11], rheumatoid
arthritis [12, 13], hepatic ischemia-reperfusion injury [14],
and renal disease [15, 16] among others.
Oxidative stress within the vasculature plays multiple
roles in the development of atherosclerosis, particularly
with regard to oxidative modifications of lipoproteins
[17]. Monocytes and neutrophils, cells that do not accu-
mulate appreciably in atherosclerotic plaques, typically
contain high levels of MPO. Yet, a subset of monocyte-
derived macrophages in human atheromatous lesions re-
tain MPO [18]. These MPO+ macrophages colocalize with
hypochlorite-modified proteins [19]. Furthermore, human
atherosclerotic plaques harbor 3-chlorotyrosine, a prod-
uct of MPO-mediated reactions [20]. Conversely, murine
macrophages from sites of atherosclerotic plaques do
not contain immunoreactive MPO or 3-chlorotyrosine
[21], making mice an inappropriate model for investigating
the role of macrophage-derived MPO in the pathogenesis
of disease. This limitation has recently been circumvented
by the creation of transgenic mice that express human
MPO, h-MPOTg [22]. Irradiated LDL-receptor-deficient
(LDLR/) animals receiving bone marrow from transgenic
animals develop accelerated atherosclerosis during
hypercholesterolemia when compared to those with
wild-type donors. MPO resides within plaques from the
transgenic, but not wild-type, BM recipients. Moreover, el-
evated levels of plasma MPO independently predict risk
for coronary events and myocardial infarction in clinical
studies [23–25].
Within the context of cardiovascular disease, the effects
of HOCl on tissue are numerous. For example, hypochlo-
rite can cause endothelial cell (EC) apoptosis, a process
during which the dying ECs release tissue factors that, November 2007 ª2007 Elsevier Ltd All rights reserved 1221
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atize both low- and high-density lipoproteins. Along with
numerous other oxidants, it oxidizes LDL to OxLDL,
a proatherogenic form that readily enters macrophages,
thus promoting foam cell formation in early lesion devel-
opment [27–29]. Oxidized LDL has chemotactic activity
[30–32] and is immunogenic [33, 34]. Hypochlorite oxi-
dizes tyrosine 192 on apo-A1, the major protein of HDL
[35]. This oxidation impairs cholesterol transport via the
cell membrane transporter ATP binding cassette trans-
porter A1 (ABCA-1) [36, 37].
To study the contribution of oxidative species to disease
processes, a number of fluorescent probes have been de-
veloped. Most detect multiple reactive oxygen species
(ROS) and can be prone to auto-oxidation. It is likely that
different ROS play distinct roles in specific pathological
processes, hence methods for selective detection of
specific ROS are desirable. To this end, Setsukinai et al.
[38] developed two novel auto-oxidation resistant
fluoroscein-based probes, 2-[6-(40-hydroxy)phenoxy-3H-
xanthen-3-on-9-yl]benzoic acid (APF) and 2-[6-(40-amino)
phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (HPF), which
detect only the highly reactive oxygen species (hROS)
hydroxyl radical (OH$), peroxynitrite (ONOO), and HOCl.
Furthermore, because APF but not HPF detects HOCl,
use of the two probes in tandem might distinguish HOCl
presence from other hROS.
Modification of the APF probe to render it detectable
with longer emission wavelengths would increase its suit-
ability for bioimaging since lipids and hemoglobin within
normal tissue absorb light within the visible light range
(which includes the emission spectrum of fluorescein,
520 nm). In particular, elastin produces strong green
autofluorescence in arteries, rendering probes that emit
in the green range unsuitable for atherosclerosis research.
The absorption coefficient of tissue components is lowest
in the far red/near infra red (NIR) range from approximately
650–900 nm [39]. In this work, development of a water-
soluble probe for hypochlorite, SNAPF, which has maximal
excitation and emission wavelengths of 614 and 676 nm,
respectively, is reported.
The current study investigated the utility of SNAPF as
a sensor for the detection of HOCl-generating MPO posi-
tive cells and, thus, probable oxidative stress-related
damage, in inflammatory states. We demonstrate that
SNAPF detects HOCl formation after stimulation of human
neutrophils, MPO-containing human macrophages, and
transgenic mouse macrophages that express human
MPO. In addition, we demonstrate the ability of SNAPF
to detect HOCl generation in vivo, and consequently to
potentially directly implicate HOCl-mediated tissue injury
in inflammation in a noninvasive manner by using fluores-
cence reflectance imaging (FRI).
RESULTS
SNAPF Probe Synthesis and Characterization
In an effort to prepare a water-soluble far-red or NIR probe
for hypochlorite, a xanthene-based dye scaffold was1222 Chemistry & Biology 14, 1221–1231, November 2007 ª20chosen. This allowed for the preparation of red-shifted
hypochlorite sensors based on an activation strategy sim-
ilar to that reported for APF, where oxidative cleavage of
a 4-aminophenylether modified fluorescein, which has
quenched fluorescence, results in generation of free fluo-
rescein with strong fluorescence emission. SNAPF is
prepared in a three-step process from sulfonaphthofluor-
escein, 1, as detailed in Figure 1A. The 4-nitrophenyl mod-
ified intermediate 2was prepared in moderate yield by nu-
cleophilic attack of dye 1 on 1-fluoro-4-nitrobenzene in the
presence of sodium carbonate. The nitro group of 2 is then
reduced with hydrogen gas in the presence of palladium
on carbon catalyst to yield crude SNAPF. During the
course of this reduction, a significant amount of free dye
1 is generated. Dye 1 and SNAPF have nearly identical
retention times by HPLC and cannot be resolved easily.
To facilitate isolation of pure SNAPF, the crude reduction
product was protected with BOC anhydride. This enabled
easy separation of the mono- and di-BOC functionalized
SNAPF derivatives, 3a and 3b, respectively, by prepara-
tive HPLC. Purified SNAPF is then isolated by treatment
of 3a and 3b with a methanolic solution of TFA.
As with APF, the reaction of SNAPF with strong oxidants
results in oxidative cleavage of the 4-aminophenyl moiety,
generating highly fluorescent free dye 1 (Figure 1B). Treat-
ment of SNAPF with excess HOCl in PBS results in
a greater than 8-fold increase in fluorescence emission
(Figure 1C), which corresponds to generation of 1. Once
generated, deprotonated dye 1 has an absorption maxi-
mum at 614 nm and emission at 676 nm [40].
SNAPF Detects Chemically and Enzymatically
Generated HOCl In Vitro
To establish which oxidative species SNAPF reports, we
exposed 10 mM SNAPF solutions to a range of chemically
generated oxidants (Figure 2A). Of the oxidants tested,
a significant increase in fluorescence occurs only with
HOCl, indicating the selectivity of SNAPF for hypochlorite.
In addition, the fluorescence emission of activated SNAPF
after exposure to HOCl increases in a concentration-
dependent manner (Figure 2B).
SNAPF can also detect HOCl generated by purified
MPO, after incubation with the enzyme at 37C for 30
min. As expected, the probe (at 10 mM) does not detect
generation of HOCl in this system in the absence of the
required MPO substrate, H2O2 (Figure 2C). Preincubation
of the enzyme with 5 mM MPO inhibitor (4-aminobenzoic
acid hydrazide) before the addition of 2 mM H2O2, ablated
signal generation, although the inhibitor is not effective
when added after the peroxide, presumably due to the
high rate of HOCl generation. The MPO inhibitor similarly
affected detection of HOCl by APF (data not shown).
SNAPF Detects HOCl Generated by Stimulated
Human Neutrophils
Since MPO is expressed at high levels by neutrophils, we
wished to establish first whether SNAPF could detect
HOCl generation by these cells following activation with
PMA. Freshly isolated neutrophils incubated with 10 mM07 Elsevier Ltd All rights reserved
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(A) Synthesis of SNAPF.
(B) Activation of SNAPF.
(C) Fluorescence emission traces, exciting with 625 nm light, of SNAPF before (solid line) and after (dashed line) exposure to excess sodium
hypochlorite in PBS (pH 7.4) at room temperature for 5 min.SNAPF (or SNAPF + 2 mM MPO inhibitor) were stimulated
with PMA at a concentration of 400 nM in the buffer and
monitored by fluorescence spectrophotometry. The fluo-
rescent signal from the activated probe rapidly increased
following cell stimulation and reached a peak around
90 min poststimulation after which it appeared to remain
stable (Figure 3A). The fluorescence increase quantified
with the plate reader translated well to fluorescence mi-
croscopy; neutrophils incubated with SNAPF were visibly
brighter following PMA stimulation (Figures 3B and 3C). In
both quantitative and qualitative data sets, coincubation
of the neutrophils with MPO inhibitor ablated the fluores-
cence of SNAPF following cell stimulation (Figures 3A
and 3D). Coincubation with MPO inhibitor at a final con-
centration of 2 mM was found to be sufficient to diminish
the fluorescent signal.
SNAPF Detects HOCl Generated from Stimulated
Murine Macrophages Transgenic for Human MPO
As noted above, mouse macrophages do not express
MPO. Therefore, to examine whether SNAPF can detect
HOCl generated by stimulation of MPO-containing macro-
phages, we first isolated and cultured bone marrow-
derived macrophages, by using standard techniques,
from mice transgenic for human MPO with age-matched
wild-type mice as controls. Reverse transcriptase amplifi-
cation of cDNA reveals transcription of the hMPO gene in
h-MPOTg, but not WT, mice (Figure 4A). The translated
protein is enzymatically active (Figure 4B). FluorescenceChemistry & Biology 14, 1221–1231readings of stimulated h-MPOTg and WT BM-derived
macrophages coincubated with probe taken over a
90 min time period show a 25% increase in h-MPOTg
cell fluorescence that peaks around 15 min poststimula-
tion and reaches a statistically significant difference from
WT cells by 75 min poststimulation (Figure 4C). h-MPOTg
or WT macrophages cultured in 96-well plates were also
used to demonstrate visually the poststimulation increase
in fluorescence observed with the plate readers via
fluorescence microscopy. h-MPOTg, but not WT, macro-
phages show an increase in fluorescence following stimu-
lation abrogated by coincubation with 2 mM MPO inhibitor
(Figures 5A–5F).
SNAPF Identifies HOCl Generated fromStimulated
Human MPO-Containing Macrophages
To study whether SNAPF can detect HOCl generated by
stimulation of MPO+ human macrophages, human mono-
cytes were isolated from whole blood and then cultured to
either the MPO-expressing phenotype (MPOhi, cultured in
serum free media with addition of GM-CSF [26]) or as clas-
sical macrophages (MPOlo). MPOlo cells do not contain
any MPO protein as previously shown by western blotting
[26]. MPOhi cells contain enzymatically active MPO that
produce HOCl after stimulation of the cells with PMA as
measured by the oxidation of TNB to DTNB in a taurine-
containing buffer (Figure 4B). Unstimulated MPOhi cells
do not demonstrate HOCl release (data not shown)., November 2007 ª2007 Elsevier Ltd All rights reserved 1223
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with PMA at a final concentration of 400 nM by using a fluo-
rescent plate reader and achieved results similar to those
for h-MPOTg macrophages (Figure 4D). In this case, fluo-
rescence emission from the activated probe in MPOhi
cells peaked at around 60 min poststimulation, although
the fluorescence signal was statistically different from
WT fluorescence earlier in the time course, at 15–30 min
poststimulation. The increase in fluorescence was also
imaged after stimulation of human MPOhi and MPOlo cells
by fluorescence microscopy, and again results compara-
ble to those from the mouse experiments were found
(Figures 5G–5L).
Figure 2. Fluorescence Response of SNAPF after Activation
(A) SNAPF selectively detects HOCl when reacted against a panel of
biological oxidants. All oxidants are 100 mM except HOCl, which is
10 mM, and were generated as described previously [38] (n = 3).
(B) Briefly, increasing concentrations of native HOCl result in an
increase in SNAPF-generated fluorescence (n = 3).
(C) Purified MPO, 11.2 nM, generates increasing amounts of SNAPF-
detectable HOCl when higher amounts of H2O2 are added as sub-
strate. Fluorescence generated by addition of 2 mM H2O2 is ablated
by coincubation of MPO with a selective MPO inhibitor at a final
concentration of 5 mM (n = 3). Error bars represent the SEM.1224 Chemistry & Biology 14, 1221–1231, November 2007 ª20SNAPF Detects HOCl Generation In Vivo
We first determined whether the increase in fluorescence
of activated SNAPF could be distinguished by FRI in vitro.
Incubation of 10 mM SNAPF with 20 mM HOCl at 37C for
30 min results in a 7-fold increase in fluorescence of the
probe as detected by FRI (Figure 6A). Given this result,
we subsequently injected the probe (50 nmoles) into
h-MPOTg mice that had peritonitis induced by thioglycol-
late. Thioglycollate was injected 24 hr before probe
administration, providing an expected mix of about 60%
neutrophils and 40% monocytes/macrophages in the
peritoneal inflammatory milieu2. When SNAPF was in-
jected i.p., a 1.4-fold increase in fluorescence of the peri-
toneum in vivo is observed after 1 hr (Figures 6B–6D).
Fluorescence emission did not increase when SNAPF
was injected into control mice, nor did fluorescence in-
crease in animals with peritonitis and control mice when
dye 1 is used as a control in place of SNAPF (Figure 6B).
SNAPF Detects HOCl in Human
Atherosclerotic Plaque
Having established that the probe can detect MPO activity
in isolated cells and in whole animals in vivo, we deter-
mined whether we could use SNAPF to provide direct
evidence of HOCl in human atherosclerotic plaque. Frozen
sections of atherosclerotic human carotid arteries yielded
SNAPF-derived fluorescence. This fluorescence is dis-
tinct from autofluorescence visible through the FITC filter
set (Figures 7A–7C). Subsequent immunohistochemical
staining of parallel sections colocalized both macro-
phages and MPO with the fluorescent areas (Figures 7D
and 7E). SNAPF was also incubated with thinly sliced
Figure 3. SNAPF Detects HOCl Generated by Stimulated
Human Neutrophils
SNAPF, coincubated with neutrophils isolated from fresh venous
blood, fluoresces after stimulation of the neutrophils with 400 nM
PMA. The fluorescence emission is quantifiable on a plate reader (A,
data points represent the mean + SEM, n = 3), and the increase in fluo-
rescence is sufficient to permit imaging by fluorescence microscopy
(B–D). Neutrophils coincubated with SNAPF pre- (B) and poststimula-
tion (C) with PMA. The increase in fluorescence post stimulation is
attenuated by coincubation with 2 mM MPO inhibitor (A and D) (n = 4).07 Elsevier Ltd All rights reserved
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carotid arteries and again showed highly fluorescent re-
gions on fluorescence microscopy, suggesting probe ac-
tivation (Figures 7E–7G). Following imaging, the sections
were frozen in OCT and sectioned to 6 mm thick slices.
Immunohistochemistry demonstrated the presence of
MPO+ cells and macrophages within the samples (Figures
7H and 7I).
DISCUSSION
Oxidative stress has far reaching effects within living tis-
sue. We now understand that not all biological oxidants
behave in the same manner in, or have equivalent effects
Figure 4. MPO+ Macrophages Contain Active MPO that Gen-
erates HOCl Detectable by SNAPF, Following Stimulation
(A) The gene for hMPO is transcribed in bone marrow-derived macro-
phages from hMPO-Tg, but not WT, mice as demonstrated by
RT-PCR.
(B) This is translated into functionally active MPO, established by
a dTNB assay. Results are expressed as a percentage decrease in ab-
sorbance at 412 nm per mg protein (n = 3). Enzymatically active MPO is
also present in human MPOhi cells (B) (n = 4).
(C and D) HOCl generated by hMPO-Tg BM macrophages (C) (n = 3)
or human MPOhi macrophages (D) (n = 5) is quantifiably detected
by SNAPF with a fluorescent plate reader, following cell stimulation
with 400 nM PMA. Results are expressed as a percentage change in
fluorescence from baseline readings (prestimulation) over time. Data
points represent the mean + SEM.Chemistry & Biology 14, 1221–1231on, cells and tissues. Tools that report the distinct roles
of different oxidant species in disease processes would
help unravel pathophysiologic mechanisms and might
ultimately furnish insight enabling the development and
evaluation of more targeted therapies. MPO produces
a number of oxidants, one of which is HOCl. To distinguish
the action of HOCl from other oxidants, as we become
increasingly aware of the multiplicity of its effects on tissue
components, would provide valuable insights into oxida-
tive mechanisms in diverse diseases. The SNAPF probe
described in this work can selectively detect HOCl, includ-
ing that generated by purified MPO. No other fluorescent
probe thus far has shown such high specificity for HOCl
over other biologically relevant oxidants, although the
prior sensors, HPF and APF, might be used in tandem to
distinguish HOCl from hydroxyl radical and peroxynitrite.
SNAPF obviates the need for dual probes in the detection
of HOCl. In addition SNAPF has absorption and fluores-
cence emission maxima in the far red, which maximizes
tissue penetration and minimizes the potential of interfer-
ence from tissue autofluorescence, a particular concern in
the study of elastin-rich arterial tissues. We demonstrated
that SNAPF can detect HOCl generated from stimulated
human neutrophils, the classic source of MPO. Thus,
this probe could serve as a valuable tool for investigation
of multiple disease states characterized by acute inflam-
mation involving infiltration of polymorphonuclear mono-
cytes.
In our experiments, human and murine MPO+ macro-
phages appear to generate sufficient HOCl after
stimulation with PMA to be detected by SNAPF, both
quantitatively and qualitatively. Although PMA is not a
physiologically relevant stimulus in the context of
atheroma, HOCl production in MPOhi macrophages is
expected following cell activation by stimulants present
within an atherosclerotic lesion, such as CD40L and
cholesterol crystals [41]. This study aimed to determine
whether SNAPF could detect HOCl generated from living
cells; for this purpose, stimulation with PMA was appropri-
ate as our previous studies showed that MPOhi cells stim-
ulated with PMA generate substantial HOCl. A study using
an alternative stimulus, N-formyl-methionylleucylphenyla-
lanine (FMLP), demonstrated that stimulation of human
neutrophils preincubated with tumor necrosis factor-a re-
sulted in rapid accumulation of HOCl over the first 30 min
of stimulation, reaching a maximum concentration approx-
imately 60 min poststimulation [42]. Fluorescence time
course data using SNAPF to detect HOCl also suggests
a rapid generation of HOCl following cell stimulation, with
comparable times for maximum concentration reached
(60–75 min for macrophages, 90 min for neutrophils).
Since degranulation of certain leukocytes following
stimulation releases preformed MPO, we may expect the
extracellular milieu to become highly fluorescent when
cells are incubated with SNAPF. Instead, we see en-
hanced fluorescence of cells themselves, in agreement
with the previous data from Setsukinai et al., who demon-
strated increased fluorescence of porcine neutrophils in-
cubated with APF following stimulation [38]. The reasons, November 2007 ª2007 Elsevier Ltd All rights reserved 1225
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Fluorescent Probe for Hypochlorite DetectionFigure 5. SNAPF Is Activated upon Incubation with MPO+ Macrophages Stimulated with PMA, Detectable by Fluorescence
Microscopy
BM-derived macrophages from h-MPOTg and WT mice, or human MPOhi or MPOlo macrophages, were incubated with 10 mM SNAPF for 10 min
prior to stimulation with 400 nM PMA. Images were acquired 30 min poststimulation with an APC filter set.
(A) h-MPOTg cells prestimulation.
(B) h-MPOTg cells poststimulation.
(C) h-MPOTg cells coincubated with 2 mM MPO inhibitor, poststimulation.
(D and E) WT cells pre- and poststimulation.
(F and G) MPOhi cells pre- and poststimulation.
(H) MPOhi cells poststimulation coincubated with MPO inhibitor.
(I and J) MPOlo cells pre- and poststimulation. Results are representative of at least three separate experiments.for this may be twofold: the probe may be taken up into the
cells by pinocytosis (as suggested for APF) and activated
intracellularly by HOCl generation within phagocytic vesi-
cles. Also, it is believed that extracellularly released HOCl1226 Chemistry & Biology 14, 1221–1231, November 2007 ª20is short lived and acts very locally, which may give the ap-
pearance of the macrophages or neutrophils becoming
fluorescent as SNAPF is activated in close proximity to
the cells.Figure 6. FRI Imaging Reveals SNAPF
Activation by HOCl In Vivo
Comparison of FRI images of SNAPF alone or
incubated with 20 mM HOCl shows an approx-
imate 7-fold increase in SNAPF fluorescence
in vitro by using this imaging system (A). We
then injected 50 nanomoles of SNAPF i.p.
into hMPO-Tg mice with thioglycollate-
induced peritonitis and imaged the animals
after 1 hr. There was a 1.4-fold increase in
peritnoneal fluorescence (B), presumably due
to contact of SNAPF with HOCl generated by
activated neutrophils and macrophages
present. Fluorescence was 1.6-fold higher
post-SNAPF injection in mice injected with
thioglycollate as opposed to water. Error bars
indicate standard deviation. (C) FRI image of
h-MPOtg mouse pre-SNAPF injection; (D) the
same animal postinjection of SNAPF. There
was no visible fluorescence when SNAPF
was injected into mice that had been injected
with saline solution as opposed to thioglycol-
late, nor was there any increase in fluores-
cence of a wavelength-matched control dye,
1, when injected into mice with peritonitis com-
pared to saline-injected animals (B) (n = 4 per
group).07 Elsevier Ltd All rights reserved
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Generation in Frozen Sections of Human
Atherosclerotic Plaque and Is Activated
after Incubation with Fresh Atheroma-
tous Carotid Endarterectomies
Frozen serial sections cut from atheromatous
carotid endarterectomies (n = 4) were incu-
bated at 37C for 1 hr with 10 mM SNAPF, or
with buffer alone as a control, and then viewed
by fluorescence microscopy. Sections incu-
bated with SNAPF were observed with an
APC (A, colored in red) and a FITC (B, colored
in green) filter set. Merged images (C) show
that fluorescent areas with the APC filter set,
which detects SNAPF, are distinct from areas
that fluoresce with the FITC filter set (autofluor-
escence). The areas which are fluorescent with
the APC filter set correspond to the location of
MPO+ cells in the section (D). Freshly excised
human endarterectomies (n = 4) were obtained
from the operating theaters of the Brigham and
Women’s Hospital, cut into thin slices, and in-
cubated with 10 mM SNAPF at 37C for 1 hr.
The slices were then viewed under a fluores-
cent microscope. Areas which were fluores-
cent when viewed with the APC filter set (E,
pseudocolored in red) were not fluorescent
with the FITC filter set (F, green) when exposed
for the same amount of time, indicating that
this was likely not autofluorescence. Merged
images show distinct red colored areas (G).
The slices contained MPO+ cells, established
by immunohistochemical staining of adjacent
tissue (H). MPO+ cells colocalized with cells,
which stained positively for macrophages in
adjacent sections (I).The in vitro experiments demonstrate that SNAPF
reports HOCl at concentrations as low as 2 mM. Due to
the short-lived nature of HOCl, however, it is difficult to
measure accurately HOCl levels in vivo. In vitro experi-
ments have shown that 1 3 106 neutrophils/ml will gener-
ate 43 mM HOCl 60 min after stimulation with PMA [43].
The sensitivity of SNAPF should therefore suffice to detect
levels of HOCl expected even in a low-grade hypochlorite-
induced oxidative state.
Results from the concurrent use of the MPO inhibitor
with SNAPF in these studies suggest that the observed
increases in fluorescence likely result from the specific
reaction of SNAPF with MPO-derived HOCl. As an addi-
tional control for both in vivo whole-animal experiments,
and in vitro cell culture work, we used sulfonaphthofluor-
escein, 1, in place of SNAPF. Fluorescence emission did
not increase in any of the experiments with the free dye
1, thereby excluding activation of the naphthofluorescein
itself by HOCl.
As well as cell culture-derived HOCl, SNAPF detects
HOCl generation in both fresh and frozen samples of
atherosclerotic human arteries and in vivo in mice with thi-
oglycollate induced peritonitis. We believe this is the firstChemistry & Biology 14, 1221–123described direct imaging evidence of HOCl within athero-
sclerotic plaque; previous reports have by necessity
focused on the presence of HOCl-modified proteins within
lesions and atheromatous vessel walls [19, 20, 36]. In its
current form, SNAPF does not lend itself to in vivo imaging
by intravenous injection due to the small size of the mole-
cule. We find that in experimental peritonitis the rapid
washout time of the probe makes it impractical for this
purpose. Conjugation of the sensor moiety to a nonimmu-
nogenic pegylated copolymer, a technique used in our
laboratory, might evade this problem, and should be a
goal of future research.
The excitation and emission wavelengths employed by
SNAPF render the probe suitable for in vivo imaging, up to
a tissue depth of around 1 cm. Use of these longer wave-
lengths circumvents difficulties found with the majority of
currently available fluorescent sensors for oxidative
species, which utilize shorter wavelengths [44]. Although
these probes certainly have value for in vitro studies,
imaging the molecular processes that occur in vivo re-
quires imaging modalities that use fluorescent sensors
less affected by normal tissue components. SNAPF could
provide such a sensor.1, November 2007 ª2007 Elsevier Ltd All rights reserved 1227
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Traditional methods of visualizing vascular disease,
such as angiography or ultrasound, furnish valuable
tools in the evaluation of atherosclerosis. These mo-
dalities, however, have considerable limitations as
they reflect anatomy or structure rather than functions
or molecular processes. Too often, atherosclerosis is
only diagnosed after the onset of symptoms, when the
disease is already quite advanced. Preclinical diagno-
sis of atherosclerosis is thus a major unmet medical
need. Detection of structural changes in the vascula-
ture such as arterial calcification or stenosis may not
distinguish functional aspects of plaques that corre-
late with their propensity to provoke thromboses,
and hence clinical events such as stroke ormyocardial
infarction. Novel methods utilizing molecular imaging
techniques can complement the more established
approaches by offering a window into the dynamic
biological processes such as inflammation by which
a plaque may develop or become susceptible to rup-
ture, invisible to traditional imaging techniques. Imag-
ing techniques that report on specific disease-related
molecular events, reaching beyond anatomy, may
ultimately allow for the identification of vulnerable
plaques before they precipitate disastrous clinical
events. Such approaches could also provide much-
needed tools for proof-of-concept studies and initial
clinical evaluation of novel therapeutics. To this end,
we have developed a novel fluorescent probe, SNAPF,
which is active in the far red range of light and selec-
tively detects HOCl, an oxidant that is implicated in
many disease processes including atherosclerosis.
Indeed, we have provided direct evidence of the pres-
ence of HOCl within human atherosclerotic plaque, an
accomplishment previously hindered by the short
half-life of the oxidant. The present results, including
the use of SNAPF in a noninvasive in vivo imaging
study, indicate that SNAPF could provide a valuable
tool to monitor selectively the impact of HOCl on the
atherogenic process, as well as other diseases,
in vivo.
EXPERIMENTAL PROCEDURES
General Considerations
APF and HPF were purchased from Alexis Biochemicals, ferrous per-
chlorate was obtained from GFS Chemicals (Columbus, OH), and
recombinant human GM-CSF and recombinant mouse G-CSF from
Cell Sciences (Canton, MA). Bovine liver catalase, Krebs-Henseleit
buffer, taurine, 5,50-dithio-bis(2-nitrobenzoic acid), 3-(aminopropyl)-
1-hydroxy-3-isopropyl-2-oxo-1-triazene, 10% palladium on carbon,
hydrogen gas, and 1-fluoro-4-nitrobenzene were all purchased from
Sigma-Aldrich (St. Louis, MO). Hydrogen peroxide was purchased
from EMD Chemicals, Inc. (Gibbstown, NJ), MPO and MPO inhibitor
(4-aminobenzoic acid hydrazide) from EMD Biosciences, Inc. (San
Diego, CA), rabbit anti-myeloperoxidase from Biodesign (Saco, ME),
and 2,20-azobis (2-amidinopropane) dihydrochloride from Wako
Chemicals USA, Inc. (Richmond, VA). Compound 1 was prepared as
reported [40]. All microwave reactions were performed with a CEM
(Matthews, NC) Discover LabMate microwave reactor. Preparative1228 Chemistry & Biology 14, 1221–1231, November 2007 ª2high performance liquid chromatography (HPLC) was performed on
Varian (Palo Alto, Ca) ProStar instrument with a ProStar UV/Vis detec-
tor model 320 set at 500 nm. All HPLC data were collected with
a Grace-Vydac (Columbia, MD) column, part number 218TP5210,
with a flow rate of 6 ml/min, unless noted otherwise. Buffer A consisted
of water and 0.1% TFA, whereas buffer B was composed of 90%
acetonitrile, 9.9% water, and 0.1% TFA. Nuclear magnetic resonance
spectra were acquired on a Bruker Biospin (Billerica, MA) DPX-400
spectrometer at ambient temperature and referenced to tetramethylsi-
lane (TMS) as an internal standard. High-resolution electrospray ioni-
zation (ESI) mass spectra were collected on a Bruker Daltonics (Biller-
ica, MA) APEXII 3 T Fourier transform mass spectrometer in the
Department of Chemistry Instrumentation Facility (DCIF) at the Massa-
chusetts Institute of Technology. Low-resolution ESI mass spectra
were obtained on a ZQ mass detector from Waters Corp. (Milford,
MA). Fluorescence data were collected on a Horiba Jobin Yvon
(Edison, NJ) Fluorolog-3 spectrofluorometer and were corrected for
the detector sensitivity.
Mice
C57BL/6J mice transgenic for human MPO (h-MPOTg) were engi-
neered as described previously [22]. WT C57BL/6 mice were pur-
chased from Taconic. All mice were housed in a specified pathogen
free environment with 12 hr light/dark cycles and were given free
access to standard chow and water. Before in vivo imaging, mice
were transferred to a nonfluorescent diet (AIN-76 purified diet, Harlan)
for at least 5 days.
Probe Synthesis
Intermediate 2. To a solution of 1 (592 mg, 1.1 mmol) in 25 ml anhydrous
dimethylformamide (DMF) was added sodium carbonate (424 mg,
4 mmol). The mixture was heated in an oil bath until a blue suspension
was obtained. To this suspension was added 1-fluoro-4-nitrobenzene
(564 mg, 4 mmol), and the reaction was heated to 175C with a
microwave reactor in a sealed reaction vessel for 15 min. Upon cooling,
the excess sodium carbonate was filtered off, and the filtrate was con-
centrated to 5 ml by rotary evaporation. The crude product was then
precipitated by addition of tert-butyl methyl ether (40 ml). The precipi-
tate was isolated by centrifugation and washed with an additional por-
tion of tert-butyl methyl ether (40 ml). This crude material was purified
by reverse phase column chromatography with a 70 g RPC18 Isolute
cartridge (Biotage, Charlottesville, VA) (eluting with: water, 0.1% TFA,
and a 0 to 50% MeOH gradient in 10% increments) to afford pure 2
(285 mg, 39%) as an brown-orange solid. 1H NMR (400 MHz, d6-
DMSO): d 9.07 (1H, d, J = 8.0 Hz), 8.91 (1H, d, J = 8.0 Hz), 8.41 (1H,
s), 8.36 (2H, d, J = 8.9 Hz), 8.00 (1H, d, J = 9.2 Hz), 7.91 (1H, d, J =
7.8 Hz), 7.87 (1H, d, J = 9.4 Hz), 7.73 (1H, s), 7.61 (1H, d, J = 7.8 Hz),
7.46 (2H, d, J = 8.9 Hz), 7.41 (1H, d, J = 9.2 Hz), 7.22–7.29 (4H, m).
HRMS (ESI) [M+H]+ calculated for C33H20NO11S2
+: 670.0472, found:
670.0455.
SNAPF
To a solution of 2 (36 mg, 0.054 mmol) in MeOH (7.6 ml) and water
(0.4 ml) was added 10% palladium on carbon (10 mg). This suspension
was allowed to stir under 1 atm of H2, during which the crude product
precipitated out of solution. After stirring for 2 hr, the reaction mixture
was filtered through a 0.45 m nylon filter, and the filtrate was discarded.
The remaining solid was washed with 1:1 water/DMF (3 3 5 ml) giving
a red solution. This solution was dried by rotary evaporation, giving
crude SNAPF (8 mg) as a burgundy red solid. For purification, the
crude material was BOC protected by treatment with di-tert-butyl di-
carbonate (BOC2O) (22 mg, 0.1 mmol) and triethylamine (TEA) (13 ml,
0.1 mmol) with stirring in MeOH (2 ml) for 16 hr. This treatment results
in formation of a mixture of mono- and di-BOC protected probe, 3a
and 3b, respectively. Following solvent removal, the protected inter-
mediates were isolated by preparative RPC18 HPLC (eluting with a
gradient from 0% to 75% buffer B with a flow rate of 6 ml/min over
50 min) giving 3a (3.6 mg, 9%, LRMS (ESI) [M+H]+ calculated for007 Elsevier Ltd All rights reserved
Chemistry & Biology
Fluorescent Probe for Hypochlorite DetectionC38H30NO11S2
+: 740.13, found: 740.12) and 3b (2.0 mg, 4%, LRMS
(ESI) [M+H]+ calculated for C43H38NO13S2
+: 840.18, found: 840.35)
as orange-red solids. Intermediates 3a and 3b were then combined
and treated with 4 ml of a 1:1 MeOH/TFA solution for 15 min. After sol-
vent removal by rotary evaporation and drying in vacuo, pure SNAPF
(3.5 mg, 10%) was obtained as a red-pink solid. Prepared SNAPF
was solubilised in phosphate buffer (pH 7.4) with 0.1% DMF as a cosol-
vent and stored at 20C in stock solutions of 1 mM for experimental
use. 1H NMR (400 MHz, d6-DMSO): d 9.29 (1H, d, J = 7.9 Hz), 9.21
(1H, d, J = 8.4 Hz), 8.34 (1H, s), 8.01 (1H, d, J = 8.6 Hz), 7.93 (1H, d,
J = 9.2 Hz), 7.87 (1H, d, J = 7.8 Hz), 7.63 (1H, d, J = 9.0 Hz), 7.49–
7.44 (3H, m), 7.34–7.26 (3H, m), 7.14 (2H, d, J = 6.2 Hz), 6.98–6.92
(2H, m). HRMS (ESI) [M+H]+ calculated for C33H22NO9S2
+: 640.0731,
found: 640.0722.
Neutrophil Isolation
Neutrophils were isolated by drawing venous blood from human volun-
teers and immediately centrifuging the blood through a density gradi-
ent at room temperature (Polymorphprep, Axis-Shield). This method
separates distinct bands of mononuclear cells and polymorphonuclear
leucocytes from erythrocytes. The band containing polymorphonu-
clear leucocytes was collected and washed twice in Hanks’ balanced
salt solution (HBSS), and then the cells were resuspended in phos-
phate buffer (pH 7.4) containing 150 mM sodium chloride and the ap-
propriate fluorescent probes. Isolated cells were used in experiments
without delay.
Macrophage Isolation
Human monocytes were isolated from donated whole blood by using
a Ficoll density gradient, washed several times in HBSS, and matured
into macrophages either with, for MPOhi cells, or without (for MPOlo)
500 U/ml GM-CSF as described previously [41]. MPOhi cells were cul-
tured in serum-free medium. Murine macrophages were isolated by
flushing bone marrow from femurs and tibias of donor mice and cell
suspensions centrifuged through a Ficoll density gradient. Adherent
bone marrow derived cells were then cultured to macrophages by
adding a final concentration of 50 ng/ml M-CSF/5% fetal bovine serum
to the culture medium.
Reverse Transcriptase Polymerase Chain Reaction
RNA was isolated from bone marrow-derived macrophages by stan-
dard procedures (RNEasy mini kit, QIAGEN). cDNA was then generated
from the RNA by using a reverse transcriptase reaction (SuperscriptII
RNase reverse transcriptase, Invitrogen). cDNA samples were ampli-
fied by PCR with primers specific for human MPO (forward 50-AC
CCCTGCCAAGCTGA-30, reverse 50-GGGGATATGAGTTGGACA, an-
nealing at 53C) and mouse b-actin (forward 50-CCTGAGCGCAAGTA
CTCTGTGT-30, reverse 50-GCTGATCCACATCTGCTGGAA-30, anneal-
ing at 60C). Reverse transcriptase-PCR products were separated with
agarose gel electrophoresis.
MPO Activity
Generation of HOCl by MPO was assessed by chlorination of taurine in
Krebs-Henseleit (KH) buffer. Cultured cells were scraped into KH
buffer containing 20 mM taurine and stimulated with a final concentra-
tion of 400 nM phorbol myristate acetate (PMA) at 37C for 2 hr with
periodic shaking. The reaction was stopped by the addition of catalase
at 20 mg/ml of buffer followed by a 10 min incubation on melting ice.
Cell suspensions were then centrifuged at 13,000 rpm for 5 min at
4C, and a final concentration of 0.225 mM 5-thio-2-nitrobenzoic
acid (TNB) added to the supernatant. The reaction was allowed to pro-
ceed for 5 min in the dark. Absorbance readings were measured at
412 nm for each sample, using buffer alone with TNB as a blank. Mean-
while, cell pellets were resuspended in triton homogenizing buffer,
lysed by sonication for 1 min, and protein measurements were taken
for each sample. Results were expressed as the percent decrease in
absorbance at 412 nm from the blank sample per mg of protein.Chemistry & Biology 14, 1221–1231Fluorescence Microscopy
Cells were cultured in black, clear bottomed 96-well plates (Costar).
On the day of the experiment, cells were washed twice in HBSS and
incubated in 0.1 M sodium phosphate buffer (pH 7.4), containing
150 mM sodium chloride and appropriate probes, with or without
MPO inhibitor. Cells were incubated at 37C in the dark for 10 min,
and then prestimulation images were acquired. Cells were then stimu-
lated with PMA at a concentration of 400 nM in the buffer and incu-
bated, protected from light, at 37C for a further 60 min, after which
poststimulation images were obtained. Images were acquired with ei-
ther a FITC (excitation 480/30 nm, emission 535/40 nm) or APC (exci-
tation 620/60 nm, emission 700/75 nm) filter set on a Nikon Eclipse
TE2000U fluorescence microscope, utilizing Spot software.
Quantification of Fluorescence
Experimental cells were cultured in black, clear-bottomed 96-well
plates (Costar), washed twice with HBSS, and then incubated at
37C in the dark in sodium phosphate buffer containing 10 mM of the
indicated probes, with or without MPO inhibitor, as above. Chemical
reactions to generate the ROS were performed as described previ-
ously [38] in 0.5 ml tubes and were transferred into wells of the
96-well plates. Briefly, OH$ was generated by 100 mM ferrous perchlo-
rate/1 mM H2O2, HOCl by addition of 10 mM NaOCl, superoxide (O2
.)
by the addition of 100 mM KO2, H2O2 by addition of 100 mM H2O2, nitric
oxide (NO) by addition of 100 mM 3-(aminopropyl)-1-hydroxy-
3-isopropyl-2-oxo-1-triazene, and alkylperoxyl radical (ROO$) by addi-
tion of 100 mM 2,20-Azobis(2-amidinopropane)dihydrochloride. Each
reaction was incubated with 10 mM SNAPF. Fluorescence readings
from the plates were measured on a Safire2 plate reader (Tecan) with
Magellan software. For APF, excitation and emission filters were
495 nm and 520 nm, respectively. For SNAPF, excitation and emission
filters of 600 nm and 700 nm were used.
Human Atherosclerotic Tissue
Freshly excised atherosclerotic human carotid arteries were obtained
from the operating theaters at Brigham and Women’s Hospital, Bos-
ton, according to protocols approved by the Institutional Review
Board. Carotids were either sliced thinly and then incubated with the
probes at 37C in phosphate buffer for fluorescence imaging or were
frozen in OCT and sectioned into 6 mm thick slices. Frozen sections
were warmed to room temperature and then incubated with 100 ml of
phosphate buffer containing 10 mM probe for 1 hr, after which they
were examined by fluorescence microscopy. Serial sections were
stained immunohistochemically for macrophages (primary antibody
anti-CD68, 1:700, DAKO) or myeloperoxidase (rabbit anti-MPO,
1:400, DAKO) with 3-amino, 9-ethyl-carbazole (AEC) as a substrate.
In Vivo Imaging
Sterile peritonitis was induced in hMPO-Tg mice by intraperitoneal in-
jection of 1 ml of a 3% thioglycollate solution in water. After 24 hr, live
mice were imaged by FRI on a Siemens BonSAI system with filters for
far-red imaging (excitation 660 nm, emission 735 nm). The fluorescent
probes were injected into the mice intraperitoneally, and the animals
were imaged again after 1 hr. The changes in fluorescence signal inten-
sity over baseline were quantified by region of interest (ROI) analysis
with OsiriX version 2.5.1.
Statistical Analysis
Statistical significance was calculated by determining p values by
using the paired t test.
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